OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Advances and challenges of first-line immunotherapy for non-small cell lung cancer: A review
Haiyang Guo, Jun Zhang, Chao Qin, et al.
Medicine (2024) Vol. 103, Iss. 3, pp. e36861-e36861
Open Access | Times Cited: 5
Haiyang Guo, Jun Zhang, Chao Qin, et al.
Medicine (2024) Vol. 103, Iss. 3, pp. e36861-e36861
Open Access | Times Cited: 5
Showing 5 citing articles:
The coagulation and tumor system are directly linked through the proteolysis and activation of epidermal growth factor receptor by thrombin
Tianfa Wang, Zhiyuan Shen, Liu Yang, et al.
Oncogene (2025)
Closed Access
Tianfa Wang, Zhiyuan Shen, Liu Yang, et al.
Oncogene (2025)
Closed Access
Safety of PD-L1 inhibitors versus PD-1 inhibitors in the treatment of lung cancer: a systematic review and network meta-analysis
Jianqiao Ding, Zheyu Liu, Jing Ning, et al.
Expert Review of Anticancer Therapy (2025)
Closed Access
Jianqiao Ding, Zheyu Liu, Jing Ning, et al.
Expert Review of Anticancer Therapy (2025)
Closed Access
Interim Analysis of GALAXIES Lung-201: Phase 2, Randomized, Open-label Platform Study of Belrestotug Plus Dostarlimab in Patients (pts) With Previously Untreated Locally Advanced/Metastatic (LA/M) PD-L1 High (TPS>/=50%) Non-Small Cell Lung Cancer (NSCLC)
Michael Thomas, David R. Spigel, Ernesto Korbenfeld, et al.
Pneumologie (2025) Vol. 79, Iss. S 01, pp. S46-S47
Closed Access
Michael Thomas, David R. Spigel, Ernesto Korbenfeld, et al.
Pneumologie (2025) Vol. 79, Iss. S 01, pp. S46-S47
Closed Access
Exosomal PD-L1 in non-small cell lung Cancer: Implications for immune evasion and resistance to immunotherapy
Mojtaba Tarin, Mahsa Akbari Oryani, Hossein Javid, et al.
International Immunopharmacology (2025) Vol. 155, pp. 114519-114519
Closed Access
Mojtaba Tarin, Mahsa Akbari Oryani, Hossein Javid, et al.
International Immunopharmacology (2025) Vol. 155, pp. 114519-114519
Closed Access
Severe immune-mediated myocarditis caused by sintilimab combined with gemcitabine: a case report and literature review
Haixia Yang, Menglu Sun, Xiaohong Zhou, et al.
Frontiers in Cardiovascular Medicine (2025) Vol. 12
Open Access
Haixia Yang, Menglu Sun, Xiaohong Zhou, et al.
Frontiers in Cardiovascular Medicine (2025) Vol. 12
Open Access
Complete Favorable Response after Second-Line Immunotherapy in Stage IV Non-Small Lung Cancer with Visceral Metastases and Operated Brain Metastasis
Roxana-Andreea Rahnea-Niţă, Laura Rebegea, Radu-Valeriu Toma, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 7, pp. 754-754
Open Access
Roxana-Andreea Rahnea-Niţă, Laura Rebegea, Radu-Valeriu Toma, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 7, pp. 754-754
Open Access
Treating Multilevel Cervical Degenerative Disk Disease in a Patient With Stage IV Lung Cancer With Notable Comorbidities Using a Drug Eluting Biomaterial: A Case Report
Bryan S. Margulies, Joe C Loy, Nikhil Thakur, et al.
JAAOS Global Research and Reviews (2024) Vol. 8, Iss. 9
Open Access
Bryan S. Margulies, Joe C Loy, Nikhil Thakur, et al.
JAAOS Global Research and Reviews (2024) Vol. 8, Iss. 9
Open Access
